|
| |
URIACHThis has always been the halmark of Group Urlach throught its more than 160 years of existence,and has made it one of the leading pharmaceutical companies in Spanish and European markets.Pharmaceutical buisiness of Group Urlach include Group J.uriach y company.
| Contact Details: |
| Avda.Camf Real51-57 |
| Barcelona |
| |
| 08184 |
| Spain |
| Tel: | 902 47 15 11 |
| Fax: | 93 864 66 06 |
| Email: | corp@uriach.com |
| WWW: | www.uriach.com/
|
| |
Recent Publications by URIACH: |  |
Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study.
BACKGROUND: Rupatadine is an oral active antihistamine for the management... | 6th September, 2007
| Pharmacokinetic and Bioanalysis Department, J Uriach y Compania, SA,
| Clin Ther. 2007 May;29(5):900-8.
DOI Direct Link |
New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugs.
The synthesis and pharmacological evaluation of new water-soluble... | 16th December, 2004
| Research Center, Grupo Uriach. Av. Cami Reial, 51-57, E-08184,
| J Med Chem. 2004 Oct 21;47(22):5579-82.
DOI Direct Link |
A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
BACKGROUND: The main objective of this randomized, double-blind,... | 18th August, 2004
| Clinical Research Unit, Research Centre, J. Uriach & Cia S.A., Barcelona,
| J Investig Allergol Clin Immunol. 2004;14(1):34-40.
|
Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.
Rupatadine is a new agent for the management of diseases with allergic... | 13th January, 2004
| Research and Development Scientific Area, J. Uriach and Cia., Barcelona,
| Drugs Today (Barc). 2003 Jun;39(6):451-68.
|
[Was Arnaldus an astrologer? Astrology in the medical thought of Arnau de Vilanova]
BACKGROUND: The main objective of this randomized, double-blind,... | 31st October, 2003
| XXXIII Premio Fundacion Uriach de Historia de la Medicina.
| Med Hist (Barc). 2003;(2):1-15.
|
→View more URIACH research publications. |
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 14 individuals from URIACH using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 203 times since April 2007, the link to the organisation's website has been followed 51 times Recent Search Terms used to find this page: corp@uriach.com | corp@uriach.com | triflusal uriach | uriach | www.uriach.com | uriach | Rupatadine uriach | uriach spain address | uriach spain address | uriach spain address | . Search for more companies in Barcelona Search for more companies in This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for URIACH |
